General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsBiotech company fighting coronavirus shoots down the idea of giving US exclusive rights to vaccine
A biopharmaceutical based in Germany reportedly rejected a proposal by the US to purchase the exclusive rights to a coronavirus vaccine, according to the German news organization Mannheimer Morgen.
CureVac AG, a vaccine and therapeutics developer headquartered in Tübingen, Germany, was approached by the Trump administration to bring the company to the US, in exchange for funding, according to German newspaper Welt am Sonntag.
A German official reportedly claimed that Trump was trying to obtain the scientist's research exclusively, and that the administration wanted to get a potential vaccine "only for the United States."
CureVac investor Christof Hettich told the Mannheimer Morgen newspaper that the company wanted to develop the highly-anticipated vaccine for the whole world, and not just for single countries, according to several German news reports.
https://news.yahoo.com/biotech-company-fighting-coronavirus-shoots-211300764.html
samnsara
(17,634 posts)exboyfil
(17,865 posts)Without legislation? Even our CDC etc spins off patent rights to private companies (I had a discussion on this point with a well renowned government epidemiologist several years ago about this).
C_U_L8R
(45,014 posts)central scrutinizer
(11,659 posts)Were seeing how dangerous it is to go it alone and say fuck you to the rest of the world
Blues Heron
(5,939 posts)exclusive rights for a global pandemic? US only?
Dan
(3,579 posts)The president that we have is just a dumb selfish son-of-a-bitch. Because if a cure was found and Trump owned the rights to said cure, billions would die, to include the Maggots that he leads.
exboyfil
(17,865 posts)You won't bring up Trump.
Deal?
Hekate
(90,769 posts)I strongly suspect that, not far under the surface of this offer, were provisions to make sure that the Trump Family would profit handsomely.
This is a news story that deserves to be aired in the American newspapers and on the nightly news programs.